Who is sponsoring NCT01427985?

NCT01427985 is sponsored by University of Ulm.

What condition does NCT01427985 study?

NCT01427985 studies Newborn, Preterm, Intubation.

What drugs are being tested in NCT01427985?

Interventions: Atropine, Fentanyl, Mivacurium, Atropine, Fentanyl, Mivacurium.

What is the status of NCT01427985?

NCT01427985 is currently COMPLETED.

Last reviewed 2016-04-05 · How we verify

The Influence of Two Different Premedication Protocols for Endotracheal Intubation in Neonates on Cerebral Oxygenation

NCT01427985 Phase 4 COMPLETED

The purpose of this study is to examine the influence of premedication drugs Atropin, Fentanyl and Mivacurium and of endotracheal intubation on cerebral oxygenation and cardiac output in term and preterm newborn infants. Two different protocols of premedication are compared.

Details

Lead sponsor	University of Ulm
Phase	Phase 4
Status	COMPLETED
Enrolment	24
Start date	2011-06
Completion	2012-07

Conditions

Newborn
Preterm
Intubation

Interventions

Atropine, Fentanyl, Mivacurium
Atropine, Fentanyl, Mivacurium

Primary outcomes

Change of cerebral tissue oxygen saturation during premedication and intubation — from 1 minute before first study drug until 10 minutes after end of procedure
A baseline value of cerebral tissue oxygen saturation before first application of premedication drugs is determined. Change of cerebral tissue oxygen saturation is defined as area under this threshold from first drug application until recovery.

Countries

Germany